BridgeBio Pharma Inc (BBIO)
30.10
-0.94
(-3.04%)
USD |
NASDAQ |
May 17, 16:00
30.10
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma 1 Year Total Returns (Daily): 120.3% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | 120.3% |
May 15, 2024 | 102.0% |
May 14, 2024 | 113.7% |
May 13, 2024 | 110.4% |
May 10, 2024 | 110.4% |
May 09, 2024 | 108.8% |
May 08, 2024 | 104.9% |
May 07, 2024 | 103.1% |
May 06, 2024 | 105.3% |
May 03, 2024 | 93.26% |
May 02, 2024 | 98.71% |
May 01, 2024 | 88.49% |
April 30, 2024 | 76.45% |
April 29, 2024 | 75.41% |
April 26, 2024 | 74.11% |
April 25, 2024 | 65.96% |
April 24, 2024 | 64.56% |
April 23, 2024 | 60.33% |
April 22, 2024 | 57.87% |
April 19, 2024 | 48.32% |
April 18, 2024 | 64.69% |
April 17, 2024 | 66.20% |
April 16, 2024 | 71.23% |
April 15, 2024 | 74.83% |
April 12, 2024 | 76.75% |
Date | Value |
---|---|
April 11, 2024 | 84.64% |
April 10, 2024 | 81.59% |
April 09, 2024 | 82.13% |
April 08, 2024 | 81.10% |
April 05, 2024 | 80.94% |
April 04, 2024 | 80.56% |
April 03, 2024 | 76.40% |
April 02, 2024 | 73.70% |
April 01, 2024 | 80.82% |
March 28, 2024 | 105.7% |
March 27, 2024 | 115.5% |
March 26, 2024 | 99.73% |
March 25, 2024 | 97.25% |
March 22, 2024 | 130.4% |
March 21, 2024 | 115.3% |
March 20, 2024 | 104.5% |
March 19, 2024 | 109.8% |
March 18, 2024 | 105.2% |
March 15, 2024 | 93.40% |
March 14, 2024 | 87.71% |
March 13, 2024 | 93.87% |
March 12, 2024 | 104.1% |
March 11, 2024 | 105.8% |
March 08, 2024 | 76.71% |
March 07, 2024 | 61.73% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.69%
Minimum
Jun 13 2022
543.5%
Maximum
Dec 27 2023
52.33%
Average
59.16%
Median
1 Year Total Returns (Daily) Benchmarks
Pfizer Inc | -17.44% |
Alnylam Pharmaceuticals Inc | -20.81% |
Regenxbio Inc | -18.81% |
ACADIA Pharmaceuticals Inc | -32.13% |
Biomarin Pharmaceutical Inc | -16.36% |